Skip to main content

Table 1 Primer and probe sequences for amplification and detection

From: A novel, non-radioactive eukaryotic in vitro transcription assay for sensitive quantification of RNA polymerase II activity

Template

Primer/oligo

Sequence 5′-3′

Modification

Amplicon/probe

Plasmid pEGFP-N1

CMV-EGFP-frw

GGGGCGGAGCCTATGGAAAA

-

PCR product: (5′ biotinyl-)CMV-EGFP, 1136 bp

Btn-CMV-EGFP-frw

GGGGCGGAGCCTATGGAAAA

5′ biotin

CMV-EGFP-rev

TGTCGCCCTCGAACTTCACCTC

-

CMV-EGFP

EGFPfrw1

TGAGCAAGGGCGAGGAGCTGTT

-

PCR/qPCR product, 295 bp

EGFPrev1

AAGATGGTGCGCTCCTGGACGT

-

EGFPfrw2

GTGACCACCCTGACCTAC

-

qPCR product, 83 bp

EGFPrev2

ATGGCGGACTTGAAGAAG

-

EGFP-LNA1

CAGtGCtTCaGCcGCTA*

5′ FAM, 3′ BHQ1, LNA-oligo*

qPCR dual labeled probe

HeLaScribe ‘Positive Control DNA’**

HELA NUCLEAR FW

CTCATGTTTGACAGCTTATCGATCCGGGC

-

PCR product: (5′ biotinyl-)HS-DNA, 1182 bp

Btn-HELA NUCLEAR FW

CTCATGTTTGACAGCTTATCGATCCGGGC

5′ biotin

HELA NUCLEAR RV

ACAGGACGGGTGTGGTCGCCATGAT

-

HS-DNA

HNqPCRfrw1

GCCGGGCCTCTTGCGGGATAT

-

qPCR product, 132 bp

HNqPCRrev1

CGGCCAAAGCGGTCGGACAGT

-

HNqPCRfrw6

GTCCATTCCGACAGCATCGCCA

-

qPCR product, 144 bp

HNqPCRrev6

GGCTCCAAGTAGCGAAGCGAGC

-

HN_SONDE1

TGGCGTGCTGCTAGCGCTAT

5′ FAM, 3′ BHQ

qPCR dual labeled probe

  1. *Locked Nucleic Acid (LNA) - bases are depicted as lower case.
  2. **‘Positive Control DNA’ is provided with the Promega ‘HeLaScribe Nuclear Extract in vitro Transcription System’. Its DNA sequence is provided within the Additional file 1 “HeLaScribe Positive Control DNA Sequence”.